This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Mike Mitka

JAMA. 2001;286:2799-2800.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Anaheim, Calif—In the largest study to date, researchers show that statin therapy to reduce the risk of major vascular events works well in patients at high risk for heart disease. But getting patients to comply with the treatment continues to be a problem, said other investigators.

At the annual Scientific Sessions of the American Heart Association, Rory Collins, MD, of the University of Oxford and lead author of the MRC/BHF Heart Protection Study, said this study showed that statin therapy reduces the risk of myocardial infarction (MI) and ischemia by at least one third across a broad range of patients at high risk for heart disease. The results were seen even in patients with cholesterol readings below national target levels.

"These benefits are seen across this huge range of high-risk individuals—male, female, young, old—and irrespective of their cholesterol level," said Collins. "I think this will change the . . . [Full Text of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Apolipoprotein E {epsilon}4 Allele, Elevated Midlife Total Cholesterol Level, and High Midlife Systolic Blood Pressure Are Independent Risk Factors for Late-Life Alzheimer Disease
Kivipelto et al.
ANN INTERN MED 2002;137:149-155.
ABSTRACT | FULL TEXT